JP2025506019A5 - - Google Patents

Info

Publication number
JP2025506019A5
JP2025506019A5 JP2024547152A JP2024547152A JP2025506019A5 JP 2025506019 A5 JP2025506019 A5 JP 2025506019A5 JP 2024547152 A JP2024547152 A JP 2024547152A JP 2024547152 A JP2024547152 A JP 2024547152A JP 2025506019 A5 JP2025506019 A5 JP 2025506019A5
Authority
JP
Japan
Prior art keywords
pharmaceutical
administration
pharmaceutical composition
pharmaceutically acceptable
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062136 external-priority patent/WO2023154705A1/en
Publication of JP2025506019A publication Critical patent/JP2025506019A/ja
Publication of JP2025506019A5 publication Critical patent/JP2025506019A5/ja
Pending legal-status Critical Current

Links

JP2024547152A 2022-02-08 2023-02-07 トレプロスチニルイロプロスト併用療法 Pending JP2025506019A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307919P 2022-02-08 2022-02-08
US63/307,919 2022-02-08
PCT/US2023/062136 WO2023154705A1 (en) 2022-02-08 2023-02-07 Treprostinil iloprost combination therapy

Publications (2)

Publication Number Publication Date
JP2025506019A JP2025506019A (ja) 2025-03-05
JP2025506019A5 true JP2025506019A5 (enExample) 2026-02-05

Family

ID=85510816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547152A Pending JP2025506019A (ja) 2022-02-08 2023-02-07 トレプロスチニルイロプロスト併用療法

Country Status (9)

Country Link
US (1) US20230263807A1 (enExample)
EP (1) EP4475819A1 (enExample)
JP (1) JP2025506019A (enExample)
KR (1) KR20240141319A (enExample)
CN (1) CN118984697A (enExample)
AU (1) AU2023219692A1 (enExample)
CA (1) CA3243453A1 (enExample)
IL (1) IL314791A (enExample)
WO (1) WO2023154705A1 (enExample)

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485614A (en) 1946-08-29 1949-10-25 Chicago Bridge & Iron Co Stabilizing and guide apparatus for lifter roofs
US3037116A (en) 1957-07-26 1962-05-29 Weber Georges Apparatus for irradiating liquids
US3035516A (en) 1958-08-18 1962-05-22 Lee Brothers Company Stencil device
US3646509A (en) 1969-08-08 1972-02-29 Texas Instruments Inc Method for field stacking seismic data and system using write after read bulk data storage
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4547016A (en) 1984-08-13 1985-10-15 Eeco Incorporated Quick release mounting
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
IT1231076B (it) 1989-09-28 1991-11-12 Pirelli Cavi Spa Procedimento per la realizzazione di gruppo di connessione separabile per fibre ottiche riunite a nastro e gruppo di connessione con esso realizzato.
GB9011588D0 (en) 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
KR100638684B1 (ko) 1997-11-14 2006-10-27 유나이티드 세러퓨틱스 코오포레이션 말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
CA2359652A1 (en) 1999-03-31 2000-10-05 United Therapeutics Corporation Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6803386B2 (en) 2002-01-16 2004-10-12 United Therapeutics Corporation Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
US6756117B1 (en) 2002-12-20 2004-06-29 The United States Of America As Represented By The United States Department Of Energy Photonic polymer-blend structures and method for making
ES2622471T5 (es) 2003-05-22 2020-07-23 United Therapeutics Corp Compuestos y procedimientos para la administración de análogos de prostaciclina
DE602004028155D1 (de) 2003-12-16 2010-08-26 United Therapeutics Corp Verwendung von treprostinil zur behandlung von ischämischen läsionen
ATE441418T1 (de) 2003-12-16 2009-09-15 United Therapeutics Corp Verwendung von treprostinil zur verbesserung der nierenfunktion
WO2005099680A2 (en) 2004-04-12 2005-10-27 United Therapeutics, Inc. Use of treprostinil to treat neuropathic diabetic foot ulcers
JP2008507585A (ja) * 2004-07-26 2008-03-13 コセリックス インク 微粒子製剤を用いて吸入したイロプロストによる肺高血圧症の治療
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
EP2026816B1 (en) * 2006-05-15 2018-10-24 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
CN101903324B (zh) 2007-12-17 2013-07-03 联合治疗公司 一种制备Remodulin中的活性成分曲前列素的改良方法
CA2723540C (en) 2008-05-08 2016-01-05 United Therapeutics Corporation Treprostinil monohydrate
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
US8349892B2 (en) 2009-05-07 2013-01-08 United Therapeutics Corporation Solid formulations of prostacyclin analogs
ES2611187T3 (es) 2010-03-15 2017-05-05 United Therapeutics Corporation Tratamiento para hipertensión pulmonar
EP2563369A2 (en) * 2010-04-29 2013-03-06 Thrombologic APS Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
JP6046034B2 (ja) 2010-06-03 2016-12-14 ユナイテッド セラピューティクス コーポレイション トレプロスチニルの製造
CA2710725C (en) 2010-07-22 2017-08-01 Alphora Research Inc. Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
US20130345471A1 (en) 2011-03-02 2013-12-26 United Therapeutics Corporation Synthesis of intermediate for treprostinil production
US9388154B2 (en) 2011-09-12 2016-07-12 Lund Biotechnology PBC Process for preparing synthetic prostacyclins
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
LT2674413T (lt) 2012-06-15 2017-09-25 Scipharm Sąrl Treprostinilo ir jo darinių gavimo būdas
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US9758465B2 (en) 2013-04-30 2017-09-12 United Therapeutics Corporation Controlled release pharmaceutical formulations
ES2860975T3 (es) 2013-10-25 2021-10-05 Insmed Inc Compuestos de prostaciclina
JP2016538161A (ja) 2013-11-27 2016-12-08 コーニング インコーポレイテッド 基板の改善された製造のための組成
WO2015138423A1 (en) * 2014-03-11 2015-09-17 Insmed Incorporated Prostacylin compositions and methods for using the same
CN105723505B (zh) 2014-05-14 2019-03-08 富士电机株式会社 半导体装置及半导体装置的制造方法
WO2016038532A1 (en) 2014-09-09 2016-03-17 Mylan Laboratories Limited Amorphous treprostinil diethanolamine
HU231186B1 (hu) 2014-10-08 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás treprostinil és sói előállítására
US9593061B2 (en) 2014-10-20 2017-03-14 United Therapeutics Corporation Synthesis of intermediates for producing prostacyclin derivatives
AU2015349969B2 (en) 2014-11-18 2020-02-06 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
US10837038B2 (en) 2014-12-23 2020-11-17 National Technology & Engineering Solutions Of Sandia, Llc Adjusting the pH of a pretreatment solution using carbon dioxide useful for integrating saccharification and fermentation
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
EP3442062A4 (en) 2016-04-08 2019-12-18 Idemitsu Kosan Co., Ltd. BINDING AGENT FOR ELECTROCHEMICAL ELEMENT
IL262720B2 (en) * 2016-05-05 2024-06-01 Liquidia Tech Inc Dry powder treprostinil for the treatment of pulmonary hypertension
JP7220650B2 (ja) 2016-09-26 2023-02-10 ユナイテッド セラピューティクス コーポレイション トレプロスチニルプロドラッグ
US12377067B2 (en) * 2016-11-10 2025-08-05 Arena Pharmaceuticals, Inc. Methods of treating PAH with combinations of ralinepag and other agents
CA3102967A1 (en) 2018-06-07 2019-12-12 Mannkind Corporation Composition and method for inhalation
EP4017588A1 (en) 2019-08-23 2022-06-29 United Therapeutics Corporation Treprostinil prodrugs
JP2023523557A (ja) 2020-04-17 2023-06-06 ユナイテッド セラピューティクス コーポレイション 間質性肺疾患の治療における使用のためのトレプロスチニル
IL298591A (en) 2020-06-09 2023-01-01 United Therapeutics Corp Pomeryl dictopiperidine prodrugs of treprostinil

Similar Documents

Publication Publication Date Title
JP7621220B2 (ja) 疾患の処置のための鼻腔内エピネフリン製剤及び方法
Graham et al. No added benefit from nebulized amiloride in patients with cystic fibrosis
JP2024095678A5 (enExample)
US20010041190A1 (en) Method for pulmonary and oral delivery of pharmaceuticals
JP2019528320A5 (enExample)
RU2685706C2 (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
US20190321290A1 (en) Composition and method for inhalation
UA119774C2 (uk) Комбінації формотеролу і будесоніду для лікування хронічної обструктивної хвороби легень (хохл)
KR102733397B1 (ko) 비강내 에피네프린 제제 및 질환의 치료 방법
KR20030031997A (ko) 살메테롤과 플루티카손 프로피오네이트의 약제학적포뮬레이션
CN116635018A (zh) 吸入用药物组合物
JP2023523557A5 (enExample)
Shah et al. An evaluation of two aerosol delivery systems for rhDNase
JPH10500966A (ja) 経口吸入もしくは吹き込みにより投与する為の化合物、及び組成物
JP2025506019A5 (enExample)
KR20230005937A (ko) 바이러스 감염의 치료 또는 예방을 위한 클로파지민 조성물 및 방법
JP2024520912A5 (enExample)
US20150250779A1 (en) Agent for Ameliorating Chronic Obstructive Pulmonary Disease
CN107137518A (zh) 一种止喘灵雾化吸入用溶液制剂及其制备方法
CN107137502A (zh) 一种鱼腥草雾化吸入用溶液制剂及其制备方法
JP2025506019A (ja) トレプロスチニルイロプロスト併用療法
EP4051307B1 (en) Peptide for prevention or treatment of covid-19
CN121487728A (zh) 喷雾干燥的曲前列环素制剂
HK40083799A (en) Clofazimine composition and method for the treatment or prophylaxis of viral infections
Terzano et al. Corticosteroids administered by nebulization to children with bronchial asthma